Postgraduate Symposium XVIII – Biological and Medicinal Chemistry Symposium for Postgraduates
Event
Postgraduate Symposium XVIII – Biological and Medicinal Chemistry Symposium for Postgraduates
Date
Thursday 12th December, 2024
Place
The Medical Sciences Teaching Centre, University of Oxford, South Parks Rd, Oxford, OX1 3PL
Downloads and Links
X hashtag – #BMCSPostGrad24
To submit your Abstract, click here
To register, click here
To Exhibit/Sponsor, click here
Synopsis
This face to face meeting will comprise of oral and poster presentations from PhD students and post-doctoral workers researching in biological or medicinal chemistry. In addition, the agenda will feature invited keynote speakers from industry and academia.
Registration
Registration is now open! Click here to register.
This is a free symposium for PhD students, post-doctoral workers, academics and industry workers.
Who should attend
This conference will be of interest to PhD students, post-doctoral workers, academics and industry workers.
Want to become an RSC member?
To join the RSC in order to qualify for discounted registration fees at all RSC events, please follow this RSC link
Call for Abstracts
Abstract submission for oral, flash talks and poster presentations is now open. The deadline for abstract submissions is Midnight (BST), Friday 4th October, 2024, click here to submit your abstract.
Programme
| 08.30 | Registration opens, exhibition and refreshments |
|---|---|
| 09.30 | Welcome and housekeeping announcement Angela Russell |
| 09.35 | Opening Remarks John Skidmore |
| Session 1 | Chair: Thomas Lanyon-Hogg |
| 09.40 | Keynote Lecture X-ray crystallographic fragment screening for the identification of allosteric binding sites Dr Louise Walsh, Astex Pharmaceuticals |
| 10.10 | Postgraduate Talk 1 High-Throughput Modular Syntheses and Biological Evaluation of Structurally-Diverse Reactive Fragment Libraries Mr Julian Chesti, University of Leeds |
| 10.30 | Postgraduate Talk 2 Synthesis and vectorial functionalisation of unexplored N-heterocycles for fragment-based drug discovery Miss Elizabeth Bedwell, Durham University |
| 10.50 - 11.20 | Refreshment break and exhibitions |
| Session 2 | Chair: Katherine Jones |
| 11.20 | Postgraduate Talk 3 The Development of Next-Generation Reactive Electrophiles for Beyond Cysteine Covalent Drug Discovery Mr Alfred Doherty, University of Strathclyde |
| 11.40 | Student flash poster presenations |
| 11.40 FT01 Establishing a chemical biology toolbox to unravel the function of NUDIX family proteins Mr Haozhe Xiao, University of Oxford, UK 11.42 FT02 Synthesis and Antischistosomal Structure-Activity Relationship Profiling of N-Pyridazin-3-ylbenzamides Mr Harrison Banda, University of Zambia, Zambia 11.44 FT03 Can LLMs generate good molecules? Dr Max Jakobs, DeepMirror, UK 11.46 FT04 Selective CDK12 Inhibitors to Treat Myotonic Dystrophy Type 1 (DM1) Mr John Fox, University of Nottingham, UK 11.48 FT05 A Platform for the High-Throughput Screening of Reactive Fragments in Cells Mr James Rowley, University of Strathclyde, UK 11.50 FT06 Synthesis of Next Generation Inhibitors of NorA Efflux Pumps to Potentiate Antibiotics Dr Thomas Burden,Imperial College London ,UK 11.52 FT07 Identification of mild mitochondrial uncouplers and the role of transbilayer proton transport rate. Mr Ethan Pacchini, University of Technology Sydney, Australia 11.54 FT08 A novel class of thapsigargin-derived broad-spectrum antivirals Mr Benjamin Owen ,University of Nottingham, UK 11.56 FT09 Design, Synthesis, Molecular Dynamic and Quantum Chemical Parameter (DFT) Analysis of New Pyrazole Derivatives Targeting EGFR for Anticancer Activity Against Breast Cancer Ms Shaheen Ali, Jamia Hmadard University, India 11.58 FT10 Design of Novel Inhibitors for SARS-CoV-2 Nsp3 Macrodomain Mr Xinyu Wang, University of York, UK 12.00 FT11 Targeting PfCLK3 with Covalent Inhibitors: A Novel Strategy for Malaria Treatment Miss Skye Brettell, University of Glasgow, UK 12.02 FT13 RaPID Discovery of Covalent Cyclic Peptide Binders Mrs Issy Mathiesen,Francis Crick Institute, UK 12.04 FT14 Discovery & characterisation of functional Tools for studying OTUB1 Mr Jack Dainton, Imperial College London, UK 12.06 FT15 Withdrawn 12.08 FT16 Development of Potent Poly (ADP-ribose) Polymerase 1 (PARP1) Degraders for Treating Cancers Mr Harashkumar V T, Vellore Institute of Technology, India 12.10 FT17 Discovery and Synthesis of Selective Binders of a Plasmodium WD40 Repeat Protein as a Novel Drug Class Mr Mohsen Alamoudi, School of Pharmacy UCL, UK 12.12 FT18 Withdrawn 12.14 FT19 An automated chemoproteomic platform for deubiquitinase probe and inhibitor discovery in cells Miss Jiaying Zhuang, Imperial College London, UK 12.16 FT20 Synthesis, in silico and in vitro Antimicrobial Efficacy of some Amidoxime-Based Benzimidazoles and Benzimidamide motifs Dr Gbolahan Oduselu, Covenant University Bioinformatics Research (CUBRe), UK 12.18 FT21 Covalent warhead optimisations of the metallo-beta-lactamase inhibitor Aspergillomarasmine A Mr Jack Bradley, University of Liverpool, UK |
|
| 12.25 | Lunch, poster session and exhibition |
| Session 3 | Chair: Rose Bardell-Cox |
| 13.35 | Keynote lecture: From antimalarials to antibody-drug conjugates: translating basic science into cancer therapeutics Ed Tate, Imperial College London |
| 14.05 | Postgraduate Talk 4 Design and Synthesis of Heterocyclic Aminothiadiazoles as Analogues of Fast Acting 1,3,4-Oxadiazole Based Antimalarials Dr Charlie Qie, University of Liverpool |
| 14.25 | Postgraduate Talk 5 Development of an inhibitor of the mutagenic SOS response that suppresses the evolution of quinolone antibiotic resistance Mr Jacob Bradbury, Department of Pharmacology, University of Oxford |
| 14.45 - 15.05 | Refreshment break and exhibition |
| Session 4 | Chair: Mary Wheldon |
| 15.05 | Postgraduate Talk 6 Exploring Pain Relief: Dual Mechanism Compounds for Inhibiting Soluble Epoxide Hydrolase and Sigma-1 Receptors Ms Celia Escriche, University of Barcelona |
| 15.25 | Postgraduate Talk 7 Autonomous phenotype-directed discovery of chemical probes Miss Niamh Morris, Rosalind Franklin Institute |
| 15.45 | Keynote lecture Embracing Sustainability in a Small Chemistry Department Dr Verity Sabin, Cancer Research Horizons, UK |
| 16.15 | Closing Remarks Mary Wheldon |
| 16.25 | Wine mixer & prizes |
| 17.00 | Meeting close |
Sponsorship – click here to sponsor
There is no registration fee for this symposium and we are therefore seeking sponsorship from companies towards running the costs.
All sponsor logos will be displayed on the holding slides, pdf of the delegate handbook and included in the communications to delegates.
Exhibition – *FULLY BOOKED*
The exhibition stand package includes:
– A six foot trestle table and chair(s)
– Access to electricity and wi-fi
– Logo inclusion in pdf delegate handbook, rolling slides and event website
– Exhibitor’s promotional page in the pdf delegate handbook
– One stand personnel
Exhibitors
Sponsors
Organising Committee
Rose Bardell-Cox, Evotec (Treasurer)
Katherine Jones, Charles River
Tom Lanyon-Hogg, University of Oxford
Angela Russell, University of Oxford
John Skidmore, University of Cambridge
Mary Wheldon, University of Dundee (Chair)
Douglas Williamson, Nxera Pharma
Secretariat Contact and Further Information
Hg3 Conferences Ltd
+44 (0)1423 529333
E-mail
